Hemophilia Lend-Lease Program in Italy Successfully Meets Albania Factor Needs

Author:

Aledort Louis M.1,De Luca Michele23,Jose Caldes Pinilla Maria3,Zanobini Alberto4,Carli Simona5,Godo Anila6,Manastirliu Ogerta7,Kolaj Gentian8,Caja Tatiana6,Neziri Vera9

Affiliation:

1. Icahn School of Medicine at Mount Sinai, New York, NY

2. University of Modena and Reggio Emilia, Modena, Italy

3. International Health Cooperation of Tuscany, Florence, Italy

4. Meyer Hospital, Florence, Italy

5. Regional Blood Centre of Tuscany, Florence, Italy

6. Mother Teresa Hospital, Tirana, Albania

7. Mother Teresa Hospital Center, Tirana, Albania

8. Hemofilia Center, Tirana, Albania

9. Albanian Haemophilia Association, Tirana, Albania

Abstract

Abstract Many countries can not provide yet an adequate haemophilia care for their patients. Albania is among the countries that are trying now to improve its healthcare system but still do not have fully implemented it. As to the Haemophilia treatment the need of FVIII for patients exceeds the available resources thus jeopardizing the possibilities of having I place prophilaxis and/or major chirurgic treatments. Tuscany is one of the region in Italy where the rate of Albanian inhabitant people is higher. Among them many are also blood donors and the links between Italians and the Albanian community are quite strong as well as the Tuscany commitment toward Albania in the general health system (many are the programs put in place by the International Health Cooperation of Tuscany). In this context in 2013 a joint program between Hospital Mother Teresa in Tirana and Hospital Meyer in Florence was undersigned for the supply of 3 MIU of FVIII at 9 cents/I.U. from donors of the region each year for three years. Albania recognizes that hemophilia treatment is a urgent part of their healthcare plan and expects to be able soon to provide more funds to continue this program. Albania has been offered more FVIII from Italian donors for at least a 5 years period in the framework of an Italian recent law that is encouraging the use of FVIII in excess to Italian needs for other countries and with the support of Kedrion , who Is the company fractionating the plasma from Tuscany donors into finished product. Kedrion not only committed to pay for the shipping of goods from Italy to Albania but it is also acting as a partner and liaison between Tuscany and the country Industry should take note that with local philanthropy and financial support from the biologic industry one can achieve both improving healthcare and not just donating product but working with developing countries to make them support their population. Disclosures Aledort: Kedrion: Other: chair scientific advisory committee for kedrion.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3